Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre-Michel Llorca

Showing results (1-10 of 335) with videos related to

Pageof 34
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 31, 2008
Monitoring patients to improve physical health and treatment outcomePierre-Michel Llorca
Therapeutic Delivery|July 27, 2012
Discussion of prevalence and management of discomfort when swallowing pills: orodispersible tablets expand treatment options in patients with depressionPierre-Michel Llorca
Journal of Psychopharmacology (Oxford, England)|July 29, 2010
The antidepressant agomelatine improves the quality of life of depressed patients: implications for remissionPierre-Michel Llorca
Psychiatry Research|October 14, 2008
Partial compliance in schizophrenia and the impact on patient outcomesPierre-Michel Llorca
Therapie|August 23, 2008
[Prevention in schizophrenia]Pierre-Michel Llorca, Hélène Denizot
Medecine Sciences : M/S|May 26, 2025
[The research program in precision psychiatry (PEPR PROPSY), issues and challenges]Marion Leboyer, Pierre-Michel Llorca
La Revue Du Praticien|May 6, 2015
[Delusional disorders]Marion Garnier, Pierre-Michel Llorca
Therapie|December 28, 2020
Clinical research in psychopharmacology, the current situation and its perspectives. A conversation with Pierre-Michel LlorcaPierre-Michel Llorca, Luc Zimmer
International Journal of Geriatric Psychiatry|March 21, 2009
CAGE unsound for alcohol misuse in seniorsLaurent Malet, Georges Brousse, Pierre-Michel Llorca
Expert Review of Neurotherapeutics|February 9, 2010
Optimizing treatment of schizophrenia to minimize relapseLudovic Samalin, Olivier Blanc, Pierre-Michel Llorca
Pageof 34

Showing results (1-10 of 335) with videos related to

Sort By:
Pageof 34
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 31, 2008
Monitoring patients to improve physical health and treatment outcomePierre-Michel Llorca
Therapeutic Delivery|July 27, 2012
Discussion of prevalence and management of discomfort when swallowing pills: orodispersible tablets expand treatment options in patients with depressionPierre-Michel Llorca
Journal of Psychopharmacology (Oxford, England)|July 29, 2010
The antidepressant agomelatine improves the quality of life of depressed patients: implications for remissionPierre-Michel Llorca
Psychiatry Research|October 14, 2008
Partial compliance in schizophrenia and the impact on patient outcomesPierre-Michel Llorca
Therapie|August 23, 2008
[Prevention in schizophrenia]Pierre-Michel Llorca, Hélène Denizot
Medecine Sciences : M/S|May 26, 2025
[The research program in precision psychiatry (PEPR PROPSY), issues and challenges]Marion Leboyer, Pierre-Michel Llorca
La Revue Du Praticien|May 6, 2015
[Delusional disorders]Marion Garnier, Pierre-Michel Llorca
Therapie|December 28, 2020
Clinical research in psychopharmacology, the current situation and its perspectives. A conversation with Pierre-Michel LlorcaPierre-Michel Llorca, Luc Zimmer
International Journal of Geriatric Psychiatry|March 21, 2009
CAGE unsound for alcohol misuse in seniorsLaurent Malet, Georges Brousse, Pierre-Michel Llorca
Expert Review of Neurotherapeutics|February 9, 2010
Optimizing treatment of schizophrenia to minimize relapseLudovic Samalin, Olivier Blanc, Pierre-Michel Llorca
Pageof 34